IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
IPO Detail
IPO Information
Financial
Financial Report
Peer Comparison
Performance
Performance Report
Documents
Mahamaya Lifesciences IPO listing price is [●], issue price is [●], and currently trading at [●] as on [●]. Mahamaya Lifesciences IPO performance is show below with latest CAGR.
*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.
*Stock splits/Reverse Stock Split are adjusted in Issue price while calculating CAGR and current performance.
Mahamaya Lifesciences IPO is a Book Building listing on BSE SME exchange. The company is based in New Delhi and caters to Chemical - Pesticides sector. Oneview Corporate Advisors is the merchant banker of Mahamaya Lifesciences IPO. It is a SME Upcoming IPO which filed its Draft Red Herring Prospectus (DRHP) on 27th February 2025.
Mahamaya Lifesciences IPO offer price is [●] and got listed at [●]. Read Mahamaya Lifesciences IPO details mentioned above.The IPO of Mahamaya Lifesciences Limited was listed on [●]. As of today, Mahamaya Lifesciences IPO is trading at [●], compared to the previous day’s close of [●]. Read the report above for detailed IPO performance.
The issue price of Mahamaya Lifesciences IPO was [●] per equity share.
Mahamaya Lifesciences IPO was listed at ₹ on the stock exchange on [●]. The listing price is the price at which the shares started trading on the stock exchange after the IPO was completed.
As of [●], the current market price of Mahamaya Lifesciences IPO is [●].
The 52-week high for Mahamaya Lifesciences IPO is [●], while the 52-week low is [●]. These figures reflect the stock’s highest and lowest trading prices in the past one year from the current date.
The Mahamaya Lifesciences IPO listed at [●] against the issue price of [●] per equity share, showing a listing day gain/loss of -1 (-100.00%) , calculated by comparing the listing price to the issue price on the first day of trading.
The Mahamaya Lifesciences IPO stock moved from its listing price of [●] to the current price of ₹[●] per equity share, reflecting a change of 0.00% per share, calculated by subtracting the listing price from the current market price (CMP) as of today.
Based on Mahamaya Lifesciences IPO issue date of [●] and CMP of ₹[●], the estimated CAGR is approximately 0%.
*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.
*Stock splits/Reverse Stock Split are adjusted in Issue price while calculating CAGR and current performance.
Face
Value :
₹ 10
Issue
Price :
[●]
Listing Price :
[●]
Previous Day Closing
[●]
Mahamaya Lifesciences IPO may offer opportunites, depending on your investment strategy. For in-depth analysis, risk factors, and KPIs, check our detailed report on Mahamaya Lifesciences Financial Review Page
Merchant Banker(s) of Mahamaya Lifesciences IPO: Oneview Corporate Advisors Private Limited
Mahamaya Lifesciences IPO subscription was X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Mahamaya Lifesciences IPO listed at a listing price of against the offer price of .
The current market price of Mahamaya Lifesciences is .
Why Us?
